Amneal Pharmaceuticals Balance Sheet (2017-2026) | AMRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	278.31M	7.96M	8.95M	210.48M	6.20M	8.56M	25.98M	6.39M	109.28M	86.93M	7.57M	5.10M	43.77M	4.34M	7.90M	6.58M	71.54M	34.73M	282.03M	4.17M
Cash & Current Investments (Quarter)	278.31M	7.96M	8.95M	210.48M	6.20M	8.56M	25.98M	6.39M	109.28M	86.93M	7.57M	5.10M	43.77M	4.34M	7.90M	6.58M	71.54M	34.73M	282.03M	4.17M
Receivables - Net (Quarter)	652.01M	627.95M	1,191.79M	538.31M	1,109.81M	628.74M	0.49M	545.76M	674.74M	1,193.51M	1,199.98M	1,156.86M	8.77M	1.10M	775.73M	1,282.21M	807.64M	885.20M	0.47M	0.10M
Receivables - Other (Quarter)	43.88M	2.11M	1.18M	1.18M	17.75M	73.00M	1.82M	0.03M	3.36M	5.12M	9.93M	1.94M	7.88M	3.25M	1.87M	2.44M	16.33M	14.84M	24.20M	6.17M
Receivables (Quarter)	695.89M	630.07M	1,192.97M	539.48M	1,127.56M	701.74M	2.31M	545.79M	678.10M	1,198.63M	1,209.91M	1,158.80M	16.65M	4.35M	777.60M	1,284.65M	823.96M	900.04M	24.67M	6.26M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	523.38M	520.25M	489.39M	512.24M	533.03M	543.86M	530.74M	529.04M	550.56M	576.47M	581.38M	570.65M	575.62M	596.36M	612.45M	601.43M	608.97M	614.50M	606.30M	641.62M
Prepaid Assets (Quarter)	103.80M	110.21M	110.22M	121.41M	232.20M	149.65M	103.56M	81.42M	81.76M	91.44M	82.69M	87.30M	81.60M	81.96M	80.72M	88.52M	85.30M	101.51M	98.39M	103.09M
Current Assets (Quarter)	1,563.47M	1,570.34M	1,520.11M	1,389.68M	1,553.60M	1,419.83M	1,411.82M	1,307.33M	1,421.79M	1,456.08M	1,377.86M	1,380.04M	1,485.48M	1,513.29M	1,587.81M	1,510.45M	1,584.69M	1,838.48M	1,911.18M	1,797.91M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	468.42M	459.65M	514.16M	500.91M	483.62M	470.15M	469.81M	462.61M	459.11M	451.85M	447.57M	439.81M	425.38M	431.02M	424.91M	427.23M	440.33M	434.99M	442.95M	444.61M
Goodwill (Quarter)	549.09M	566.41M	593.02M	602.89M	600.97M	599.50M	598.85M	599.16M	599.21M	598.63M	598.63M	598.55M	598.53M	598.32M	597.44M	597.50M	597.41M	595.95M	595.47M	593.80M
Intangibles (Quarter)	1,293.33M	1,232.73M	1,166.92M	1,209.82M	1,204.22M	1,159.01M	1,096.09M	1,055.32M	1,015.38M	982.53M	890.42M	859.27M	819.94M	780.19M	732.38M	689.14M	649.55M	587.94M	563.50M	534.87M
Goodwill & Intangibles (Quarter)	1,842.42M	1,799.13M	1,759.94M	1,812.71M	1,805.20M	1,758.51M	1,694.95M	1,654.47M	1,614.58M	1,581.16M	1,489.05M	1,457.82M	1,418.48M	1,378.51M	1,329.81M	1,286.63M	1,246.95M	1,183.88M	1,158.97M	1,128.67M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	19.22M	19.53M	20.61M	63.94M	79.84M	108.26M	103.22M	86.43M	93.24M	89.04M	55.52M	73.75M	77.03M	36.27M	60.13M	45.42M	44.85M	39.46M	57.80M	54.88M
Non-Current Assets (Quarter)	2,459.58M	2,404.07M	2,419.56M	2,499.29M	2,487.80M	2,454.21M	2,387.52M	2,319.28M	2,279.10M	2,231.00M	2,094.71M	2,076.35M	2,024.44M	1,947.68M	1,913.64M	1,854.80M	1,838.10M	1,761.40M	1,767.10M	1,742.31M
Assets (Quarter)	4,023.05M	3,974.41M	3,939.66M	3,888.97M	4,041.41M	3,874.04M	3,799.34M	3,626.61M	3,700.89M	3,687.08M	3,472.57M	3,456.40M	3,509.92M	3,460.98M	3,501.45M	3,365.25M	3,422.79M	3,599.87M	3,678.28M	3,540.22M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	596.23M	589.41M	525.35M	539.73M	561.69M	531.46M	538.20M	467.42M	512.72M	3.50M	0.55M	1.65M	1.62M	671.09M	0.06M	0.00M	7.38M	37.09M	0.03M	0.04M
Notes Payables (Quarter)							39.71M		40.56M	41.00M	41.45M	41.89M
Payables (Quarter)	596.23M	589.41M	525.35M	539.73M	561.69M	531.46M	577.90M	467.42M	553.28M	44.50M	42.00M	43.54M	1.62M	671.09M	0.06M	0.00M	7.38M	37.09M	0.03M	0.04M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)			58.00M		275.34M	176.09M	107.48M	76.32M	77.01M	76.83M	76.99M	30.13M	30.74M	30.18M	31.75M	43.50M	41.52M	40.60M	43.26M	10.55M
Short term Debt (Quarter)	32.93M	32.47M	30.61M	30.52M	29.92M	60.00M	60.00M	14.75M	30.41M	76.00M	34.12M	179.00M	179.00M	140.00M	224.21M	31.79M	290.00M	7.20M	6.76M	6.20M
Current Leases (Quarter)	8.24M	9.18M	2.64M	3.23M	3.32M	2.81M	3.49M	2.93M	2.99M	9.83M	2.83M	3.19M	3.26M	9.70M	3.21M	3.32M	8.22M	3.46M	8.67M	8.92M
Current Taxes (Quarter)
Total Current Liabilities (Quarter)	672.86M	667.34M	677.24M	602.04M	993.06M	818.00M	752.80M	703.71M	777.35M	760.60M	846.60M	834.39M	1,114.35M	1,095.21M	1,129.77M	1,075.82M	1,107.13M	862.11M	881.63M	728.05M
Non-Current Liabilities
Capital Leases (Quarter)		60.97M	60.25M	60.29M	60.01M	61.31M	60.77M	60.24M	59.84M	59.35M	58.57M	58.81M	58.01M	57.56M	56.89M	56.60M	56.02M	55.67M	54.93M	54.88M
Non-Current Debt (Quarter)	2,720.12M	37.63M	38.04M	38.44M	38.86M	39.28M	2,591.98M	2,561.72M	2,549.18M	2,541.81M	2,386.00M	2,377.71M	2,177.58M	2,169.61M	2,161.79M	2,153.98M	2,146.40M	2,566.50M	2,565.11M	2,565.56M
Minority Interest (Quarter)	14.11M	15.26M	16.91M	16.42M	17.89M	22.38M	24.95M	27.53M	32.11M	37.14M	41.29M	47.02M	53.42M	59.89M	64.97M	72.61M	65.80M	67.78M	-0.54M	-0.56M
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	34.72M	32.56M	64.00M	18.09M	28.90M	16.65M	59.23M	15.16M	28.30M	13.60M	48.91M	26.79M	26.78M	10.27M	47.04M	8.52M	16.44M	15.68M	14.20M	13.47M
Other Non-Current Liabilities (Quarter)	63.26M	60.80M	38.90M	32.87M	79.21M	78.26M	5.93M	41.46M	0.86M	1.91M	3.21M	11.39M				10.69M	1.75M	0.48M	0.48M	26.75M
Total Non-Current Liabilities (Quarter)	2,945.81M	2,908.65M	2,878.54M	2,863.10M	2,857.47M	2,839.38M	2,837.61M	2,760.70M	2,740.66M	2,735.10M	2,564.67M	2,638.62M	2,399.64M	2,399.45M	2,416.21M	2,348.81M	2,362.39M	2,779.94M	2,790.68M	2,772.23M
Total Liabilities (Quarter)	3,632.78M	3,591.24M	3,572.69M	3,481.56M	3,868.41M	3,679.75M	3,615.36M	3,491.94M	3,550.12M	3,532.84M	3,452.56M	3,520.03M	3,567.41M	3,554.55M	3,610.96M	3,497.25M	3,535.32M	3,709.33M	3,749.07M	3,586.19M
Shareholder's Equity
Total Debt (Quarter)	2,753.05M	70.10M	68.65M	68.97M	68.78M	99.28M	2,651.98M	2,576.47M	2,579.58M	2,617.81M	2,420.13M	2,556.71M	2,356.58M	2,309.61M	2,386.00M	2,185.77M	2,436.40M	2,573.70M	2,571.88M	2,571.76M
Common Equity (Quarter)	390.27M	383.17M	366.97M	407.41M	172.99M	194.29M	183.98M	134.67M	150.77M	154.24M	20.01M	-63.63M	-57.49M	-93.57M	-109.51M	-132.00M	-112.53M	-109.46M	-70.79M	-45.97M
Shareholder's Equity (Quarter)	390.27M	383.17M	366.97M	407.41M	172.99M	194.29M	183.98M	134.67M	150.77M	154.24M	20.01M	-63.63M	-57.49M	-93.57M	-109.51M	-132.00M	-112.53M	-109.95M	-70.79M	-45.41M
Liabilities and Shareholders Equity (Quarter)	4,023.05M	3,974.41M	3,939.66M	3,888.97M	4,041.41M	3,874.04M	3,799.34M	3,626.61M	3,700.89M	3,687.08M	3,472.57M	3,456.40M	3,509.92M	3,460.98M	3,501.45M	3,365.25M	3,422.79M	3,599.87M	3,678.28M	3,540.22M
Retained Earnings (Quarter)	-265.58M	-33.23M	-276.20M	-0.35M	0.87M	12.54M	9.94M	3.76M	8.08M	3.87M	-490.18M	-23.71M	-30.44M	-575.98M	-65.51M	-594.87M	-97.43M	-105.88M	-535.00M	-472.75M
Treasury Shares (Quarter)							17.93M				17.45M				17.58M				2.22M

Research Tools

Amneal Pharmaceuticals Balance Sheet (2017-2026) | AMRX

Create an account

Sign In

Reset Password